» Articles » PMID: 31277043

Regulation of the Tenogenic Gene Expression in Equine Tenocyte-derived Induced Pluripotent Stem Cells by Mechanical Loading and Mohawk

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2019 Jul 6
PMID 31277043
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-based therapeutic strategies afford major potential advantages in the repair of injured tendons. Generation of induced pluripotent stem cells (iPSCs) expands cell sources for "regenerative" therapy. However, its application in tendon repair is still limited and the effects remain unclear. In this study, equine tenocyte-derived iPSCs (teno-iPSCs) were generated by expressing four Yamanaka factors. Compared to parental tenocytes and bone marrow derived mesenchymal stem cells (BMSCs), the transcriptional activities of lineage-specific genes, including Mkx, Col1A2, Col14, DCN, ELN, FMOD, and TNC, were highly repressed in the resulting teno-iPSCs. Exposure to cyclic uniaxial mechanical loading increased the expression of Scx, Egr1, Col1A2, DCN, and TNC in teno-iPSCs and the expression of Scx, Egr1, DCN, and TNC in BMSCs. Reintroduction of tenogenic transcription factor Mohawk (Mkx) upregulated the expression of DCN in teno-iPSCs and the expression of Scx, Col14, and FMOD in BMSCs. Mechanical loading combined with ectopic expression of equine Mkx further enhanced the expression of Egr1, Col1A2, DCN, and TNC in teno-iPSCs and the expression of Scx, Egr1, and TNC in BMSCs. These data suggest that the repressed lineage-specific genes in the teno-iPSCs can be re-activated by mechanical loading and ectopic expression of Mkx. Our findings offer new insights into the application of iPSCs for basic and clinic research in tendon repair.

Citing Articles

Cardioprotective effects of hUCMSCs-Exosi-EGR1 MN patch in MI/RI by modulating oxidative stress and mitophagy.

Huang C, Zhang X, Wu S, Chang Q, Zheng Z, Xu J Mater Today Bio. 2025; 31:101500.

PMID: 39944530 PMC: 11815289. DOI: 10.1016/j.mtbio.2025.101500.


Recent Advances in the Use of Stem Cells in Tissue Engineering and Adjunct Therapies for Tendon Reconstruction and Future Perspectives.

Dec P, Zylka M, Burszewski P, Modrzejewski A, Pawlik A Int J Mol Sci. 2024; 25(8).

PMID: 38674084 PMC: 11050411. DOI: 10.3390/ijms25084498.


Viable tendon neotissue from adult adipose-derived multipotent stromal cells.

Taguchi T, Lopez M, Takawira C Front Bioeng Biotechnol. 2024; 11:1290693.

PMID: 38260742 PMC: 10800559. DOI: 10.3389/fbioe.2023.1290693.


Equine tendon mechanical behaviour: Prospects for repair and regeneration applications.

Shojaee A Vet Med Sci. 2023; 9(5):2053-2069.

PMID: 37471573 PMC: 10508504. DOI: 10.1002/vms3.1205.


External stimulation: A potential therapeutic strategy for tendon-bone healing.

Fu S, Lan Y, Wang G, Bao D, Qin B, Zheng Q Front Bioeng Biotechnol. 2023; 11:1150290.

PMID: 37064229 PMC: 10102526. DOI: 10.3389/fbioe.2023.1150290.


References
1.
Nam H, Pingguan-Murphy B, Abbas A, Merican A, Kamarul T . The proliferation and tenogenic differentiation potential of bone marrow-derived mesenchymal stromal cell are influenced by specific uniaxial cyclic tensile loading conditions. Biomech Model Mechanobiol. 2014; 14(3):649-63. DOI: 10.1007/s10237-014-0628-y. View

2.
Barsby T, Bavin E, Guest D . Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells. Tissue Eng Part A. 2014; 20(19-20):2604-13. PMC: 4195467. DOI: 10.1089/ten.TEA.2013.0457. View

3.
Tan C, Lui P, Lee Y, Wong Y . Scx-transduced tendon-derived stem cells (tdscs) promoted better tendon repair compared to mock-transduced cells in a rat patellar tendon window injury model. PLoS One. 2014; 9(5):e97453. PMC: 4022525. DOI: 10.1371/journal.pone.0097453. View

4.
Chen X, Yin Z, Chen J, Liu H, Shen W, Fang Z . Scleraxis-overexpressed human embryonic stem cell-derived mesenchymal stem cells for tendon tissue engineering with knitted silk-collagen scaffold. Tissue Eng Part A. 2013; 20(11-12):1583-92. DOI: 10.1089/ten.TEA.2012.0656. View

5.
Docheva D, Muller S, Majewski M, Evans C . Biologics for tendon repair. Adv Drug Deliv Rev. 2014; 84:222-39. PMC: 4519231. DOI: 10.1016/j.addr.2014.11.015. View